Baird Financial Group
TMDX icon

Baird Financial Group’s Transmedics TMDX Stock Holding History

Baird Financial Group’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-21,202
Closed -$2.11M – 1985
2026
Q1 		$2.11M Buy
21,202
+7,327
+53% +$956K ﹤0.01% 1025
2025
Q4 		$1.69M Sell
13,875
-6,994
-34% -$878K ﹤0.01% 1094
2025
Q3 		$2.34M Buy
20,869
+397
+2% +$46.5K ﹤0.01% 992
2025
Q2 		$2.74M Buy
+20,472
New +$2.25M ﹤0.01% 916

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Baird Financial Group's TMDX Position: Q2 2026 in Review

Baird Financial Group sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 21,202 shares — an estimated $2.11M sold.

Baird Financial Group first reported a position in TMDX in Q2 2025 and held it in 4 quarters. The position peaked at $2.74M in Q2 2025. 374 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Baird Financial Group reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Baird Financial Group sold 21,202 Transmedics shares in Q2 2026, an estimated $2.11M.
  • Baird Financial Group first reported a position in Transmedics in Q2 2025 and held it in 4 quarters.
  • Baird Financial Group's Transmedics position peaked at $2.74M in Q2 2025.
  • 374 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.